Cost-effectiveness of clopidogrel plus aspirin vs. aspirin alone for secondary-prevention of cardiovascular events: Results from the CHARISMA trial

被引：0
|
作者：
Chen, Jersey
Bhatt, Deepak L.
Schneider, Elizabeth
Shi, Chunxue
Caro, Jaime
Proskorovsky, Irina
Hacke, Werner
Fox, Keith A.
Cohen, David J.
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Harvard Clin Res Inst, Boston, MA USA
[4] Caro Res, Concord, MA USA
[5] Univ Heidelberg, D-6900 Heidelberg, Germany
[6] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：826 / 826
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Clopidogrel plus Aspirin versus Aspirin Alone for Secondary Prevention of Cardiovascular Events: Results from the CHARISMA Trial
    Chen, Jersey
    Bhatt, Deepak L.
    Dunn, Elizabeth Schneider
    Shi, Chunxue
    Caro, J. Jaime
    Mahoney, Elizabeth M.
    Gabriel, Sylvie
    Jackson, Joseph D.
    Topol, Eric J.
    Cohen, David J.
    [J]. VALUE IN HEALTH, 2009, 12 (06) : 872 - 879
  • [2] Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone
    Rothberg, M
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 143 (06) : 464 - 464
  • [3] Cost-effectiveness of clopidogrel addition to aspirin to prevent cardiovascular events in patients with established cardiovascular disease: results from the CHARISMA trial
    Bakhai, A.
    Chen, J.
    Schneider, E.
    Bhatt, D. L.
    De Pouvourville, G.
    Willich, S. N.
    Caro, J.
    Hacke, W.
    Fox, K. A. A.
    Cohen, D. J.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 858 - 858
  • [4] Economic Evaluation of Clopidogrel Plus Aspirin for Secondary Prevention of Cardiovascular Events in Canada for Patients With Established Cardiovascular Disease: Results From the CHARISMA Trial
    Chen, Jersey
    Shi, Chunxue
    Mahoney, Elizabeth M.
    Dunn, Elizabeth Schneider
    Rinfret, Stephane
    Caro, J. Jaime
    O'Brien, Judith
    El-Hadi, Wissam
    Bhatt, Deepak L.
    Topol, Eric J.
    Cohen, David J.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (02) : 222 - 231
  • [5] Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
    Djatche L.M.
    Varga S.
    Lieberthal R.D.
    [J]. PharmacoEconomics - Open, 2018, 2 (4) : 371 - 380
  • [6] Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events
    Squizzato, Alessandro
    Bellesini, Marta
    Takeda, Andrea
    Middeldorp, Saskia
    Donadini, Marco Paolo
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (12):
  • [7] Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases
    Mei-Chuan Lee
    Chia-Te Liao
    Han Siong Toh
    Chih-Chen Chou
    Wei-Ting Chang
    Zhih-Cherng Chen
    Wen-Shiann Wu
    Tsung Yu
    Carol Strong
    [J]. Cardiovascular Drugs and Therapy, 2021, 35 : 539 - 547
  • [8] Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases
    Lee, Mei-Chuan
    Liao, Chia-Te
    Toh, Han Siong
    Chou, Chih-Chen
    Chang, Wei-Ting
    Chen, Zhih-Cherng
    Wu, Wen-Shiann
    Yu, Tsung
    Strong, Carol
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (03) : 539 - 547
  • [9] Aspirin Plus Clopidogrel vs Aspirin Alone for Preventing Cardiovascular Events Among Patients at High Risk for Cardiovascular Events
    Donadini, Marco P.
    Bellesini, Marta
    Squizzato, Alessandro
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (06): : 593 - 594
  • [10] Secondary Prevention Clopidogrel and Aspirin vs. Aspirin for Early Prophylaxis
    Diener, H. C.
    [J]. AKTUELLE NEUROLOGIE, 2013, 40 (10) : E55 - E55
12345